Celldex Therapeutics, Inc.

CLDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 12, 2026
10-Q May 7, 2026 10-Q
8-K May 7, 2026 FORM 8-K
SCHEDULE 13G/A May 6, 2026
SCHEDULE 13G Apr 29, 2026
ARS Apr 29, 2026 ARS
DEF 14A Apr 29, 2026 FORM DEF 14A
424B5 Apr 2, 2026 424B5
8-K Apr 2, 2026 FORM 8-K
424B5 Apr 1, 2026 424B5
SCHEDULE 13G/A Mar 26, 2026
SCHEDULE 13G/A Mar 10, 2026
10-K Feb 25, 2026 10-K
8-K Feb 25, 2026 FORM 8-K
SCHEDULE 13G/A Feb 10, 2026
SCHEDULE 13G Feb 9, 2026
4 Jan 6, 2026
4 Dec 17, 2025
4 Dec 8, 2025
144 Dec 4, 2025
4 Nov 17, 2025
SCHEDULE 13G Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
← Newer Page 2 of 49 · 1221 filings Older →